Author: Tim Bracey

Introduction Despite us being portrayed as an unsociable specialty, I don’t think many people would disagree that some sort of collaboration is important in our work as pathologists. Collaboration with clinicians is a vital and rewarding part of our jobs, and collaboration within our own departments is essential to a smooth-running service. In histopathology we … Continue reading “Beyond the Garden Fence. Collaborative Digital Pathology in the NHS. Time to Think National, Not Just Local”

  Dr Lucy Gardner, Foundation Year 1  & Dr Tim Bracey, Consultant Pathologist Introduction In the Summer 2024 edition of ACP news Dr Bracey discussed “what makes an expert in Histopathology”. During my F1 placement in Pathology we discussed his and local colleagues preference for gaining expert second opinions digitally, given the potential advantages this … Continue reading “The coastal path towards digital expert opinions; audit and comparison of glass slide vs a cloud based digital pathology method.”

Dr Tim Bracey. Consultant Pathologist (RCHT) Change is painful but necessary. As an aging man, I find myself increasingly resistant to it. Yet, throughout my life, I have endured my fair share of change. Growing up as the eldest child with young, enthusiastic parents who loved traveling, I attended eight different schools. When I left … Continue reading “The Challenges and Necessity of Change in Pathology”

The topic of the current ACP news issue is academic pathology. My training route into pathology was unusual, with a background in surgery, basic (biological) science, and a PhD investigating the molecular pathology of apoptosis in colorectal cancer. My background in a related research topic initially made me interested in academic pathology. My first trainer … Continue reading “What makes an expert in Histopathology?”

a potential pitfall to be aware of in head and neck FNAC practice • 70-year-old man  presents with a mass in left lateral zygoma. •On U/S there was a hypoechoic lesion in the left parotid 1.3 x 0.9 cm, and a further probable lymph node 0.5 cm in the left zygomatic area. •Following informed consent … Continue reading “Cytology Histology Correlation confirms an unusual variant of a common malignancy”

Pathologists often use immunohistochemistry (IHC) to confirm what we already know, or strongly suspect from the H&E slide. AI can now assist us in a similar way such as identifying a tiny focus of cancer in a gastric biopsy, for which we might use a cytokeratin immunostain for confirmation. Like IHC it will allow us … Continue reading “Artificial Intelligence versus immunohistochemistry”

The smoking gun?